A patient on lorazepam 0.5 mg three times daily for catatonia is now no longer catatonic; can the lorazepam dose be reduced?

Yes, you can decrease the lorazepam, but do so gradually with a slow taper to prevent catatonia relapse

The key principle is that lorazepam should be tapered slowly once catatonia has fully resolved, rather than abruptly discontinued, as sudden reduction can precipitate relapse of catatonic symptoms.

Rationale for Tapering

Your patient is no longer catatonic, which indicates successful acute treatment. However, the evidence strongly suggests that benzodiazepine discontinuation in catatonia carries specific risks:

• Relapse risk is real: Multiple case reports document catatonia re-emergence during lorazepam tapering 1, 2, 3, 4
• Some patients require prolonged maintenance: A subset of catatonia patients need extended benzodiazepine treatment, sometimes indefinitely 2, 3, 4
• Withdrawal can worsen outcomes: Abrupt discontinuation may lead to loss of benzodiazepine response or require higher doses to regain control 2

Recommended Tapering Approach

Use a gradual taper of 10-20% dose reduction per week, based on pediatric benzodiazepine withdrawal guidelines that can be extrapolated to adults 5:

1. Start by reducing one dose first - decrease the smallest daily dose (likely one of the TID doses) by 0.25 mg
2. Wait 5-7 days between each dose reduction to monitor for symptom re-emergence
3. Extend dosing intervals gradually - transition from TID → BID → daily → every other day before complete discontinuation 5
4. Monitor closely using a structured assessment tool (Bush-Francis Catatonia Rating Scale if available) 6, 7

Specific Taper Schedule Example:

• Week 1-2: 0.5 mg TID (current dose - observe stability)
• Week 3: 0.25 mg in AM, 0.5 mg midday, 0.5 mg HS
• Week 4: 0.25 mg in AM, 0.25 mg midday, 0.5 mg HS
• Week 5: 0.25 mg BID (morning and HS)
• Continue reducing by 0.25 mg every 1-2 weeks

Critical Monitoring Points

Watch for early signs of catatonia recurrence 1, 6:

• Decreased verbal output or mutism
• Motor slowing or immobility
• Posturing, negativism, or stereotypies
• Withdrawal from social interaction

If symptoms re-emerge during taper 8:

• Pause the taper immediately
• Return to the previous effective dose
• Stabilize for 2-4 weeks before attempting a slower taper
• Consider that this patient may need longer-term maintenance 2, 3, 4

Important Caveats

The underlying condition matters: Ensure the psychiatric or medical condition that precipitated catatonia is adequately treated before tapering 1. If the primary disorder (e.g., schizophrenia, mood disorder) is unstable, delay the taper.

Duration of treatment influences taper duration: The FDA label warns that "the required time for weaning can be expected to be proportional to the duration of intravenous benzodiazepine treatment" 5. While your patient is on oral therapy, the same principle applies - longer treatment requires slower tapering.

Some patients need indefinite maintenance: Published cases show that 2-4 patients out of small case series required ongoing lorazepam without successful discontinuation 2, 3, 4. If multiple taper attempts fail, long-term maintenance may be necessary.

Avoid abrupt discontinuation: The FDA label explicitly warns that "abrupt discontinuation or rapid dosage reduction may precipitate acute withdrawal reactions, which can be life-threatening" 8. For catatonia specifically, this can mean return of the syndrome 1, 2.

Alternative Consideration

If tapering proves difficult, some evidence suggests cross-tapering to clonazepam (longer half-life) may help, though this is challenging and can result in relapse 2. This should only be attempted under close supervision if standard lorazepam tapering fails repeatedly.

Bottom line: Start a slow taper now that catatonia has resolved, but be prepared to pause or reverse course if symptoms return. The total taper may take 6-12 weeks or longer depending on individual response.